🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

European shares retreat after week of gains; Allianz rallies after update

Published 17/02/2017, 10:43
© Reuters. A plastic bull figurine, symbol of the Frankfurt stock exchange is pictured in front of the German share price index DAX board at the Frankfurt stock exchange
AEGN
-
ALVG
-
DBKGn
-
CAGR
-
STAGn
-
AZN
-
GSK
-
STAN
-
VOPA
-
HG
-
STOXX
-
SX7P
-
SXDP
-

By Danilo Masoni

MILAN (Reuters) - European shares fell on Friday with gains in insurance heavyweight Allianz (DE:ALVG) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

The pan-European STOXX 600 (STOXX) index fell 0.5 percent but remained close to a 13-month high reached on Wednesday and on track to end higher for the second week in a row.

The rally has been fuelled by strong earnings updates, a pick up in merger and acquisition (M&A) activity, with cyclical stocks such as mining companies and banks lifted by solid economic data.

Allianz rose 2.4 percent. Europe's largest insurer proposed spending 3 billion euros on buying back its own shares after posting higher-than-expected profits and saying it was adjusting its policy on budgeting for possible takeovers.

The Munich-based firm also raised its dividend.

"The combination of a dividend increase and a share buy-back probably both at the upper end of market expectations is a sign of strength and should improve sentiment and provide tailwind for the shares," DZ Bank analyst Thorsten Wenzel said.

Elsewhere in the insurance sector, Dutch insurer Aegon (AS:AEGN) rose as much as 4.2 percent as investors cheered to a stronger than expected pretax profit growth. Its shares pared gains and were last up 0.3 percent.

On the M&A front, Stada (DE:STAGn) was once again in focus after the German generic drugs company said it had received its third takeover approach, valuing the company at 58 euros per share, above its current market value and higher than a previous takeover offer. Its shares rose 1.1 percent.

Some big drugmaker stocks were also in demand, lifting the healthcare index (SXDP) up slightly and making it the only sectoral gainer in Europe.

Britain's AstraZeneca (L:AZN) and GlaxoSmithKline (L:GSK) were up 1.6 percent and 0.5 percent respectively after analysts at Jefferies raised the price target for both.

Europe's STOXX bank index (SX7P) fell 1.2 percent as investors booked profits for a second day after the index hit a three-week high on Wednesday, helped by growing expectations of a rate hike next month in the United States.

Deutsche Bank (DE:DBKGn), Standard Chartered (L:STAN) and Credit Agricole (PA:CAGR) fell between 2.6 and 2.8 percent.

Miners (SXDP) were also weaker, down 1.1 percent, pulling back after climbing earlier this week to their highest level in more than two years. Copper slid on Friday because of some profit taking, but the likelihood of strong demand from top consumer China were expected to support prices.

"Short-term technicals remain in overbought territory making rounds of profit-taking...more likely," said Markus Huber, trader at City of London Markets.

© Reuters. A plastic bull figurine, symbol of the Frankfurt stock exchange is pictured in front of the German share price index DAX board at the Frankfurt stock exchange

Top loser on the STOXX was Vopak (AS:VOPA), down 8.7 percent, after the Dutch oil and chemical storage company said it did not expect core profit to grow this year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.